0.8619
price down icon2.76%   -0.0245
pre-market  Pre-mercato:  .90   0.0381   +4.42%
loading
Precedente Chiudi:
$0.8864
Aprire:
$0.89
Volume 24 ore:
432.89K
Relative Volume:
0.47
Capitalizzazione di mercato:
$111.33M
Reddito:
-
Utile/perdita netta:
$-26.91M
Rapporto P/E:
-3.9177
EPS:
-0.22
Flusso di cassa netto:
$-19.57M
1 W Prestazione:
-0.87%
1M Prestazione:
+4.35%
6M Prestazione:
-7.45%
1 anno Prestazione:
-38.44%
Intervallo 1D:
Value
$0.86
$0.89
Intervallo di 1 settimana:
Value
$0.8388
$0.8909
Portata 52W:
Value
$0.5526
$1.66

Atossa Therapeutics Inc Stock (ATOS) Company Profile

Name
Nome
Atossa Therapeutics Inc
Name
Telefono
206.588.0256
Name
Indirizzo
10202 5TH AVENUE NE, SEATTLE, WA
Name
Dipendente
13
Name
Cinguettio
@atossainc
Name
Prossima data di guadagno
2025-03-25
Name
Ultimi documenti SEC
Name
ATOS's Discussions on Twitter

Confronta ATOS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ATOS
Atossa Therapeutics Inc
0.8619 111.00M 0 -26.91M -19.57M -0.22
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Atossa Therapeutics Inc Stock (ATOS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2018-01-26 Iniziato Maxim Group Buy

Atossa Therapeutics Inc Borsa (ATOS) Ultime notizie

pulisher
01:30 AM

Does Atossa Therapeutics Inc. stock pay reliable dividendsFree Consultation - jammulinksnews.com

01:30 AM
pulisher
12:27 PM

Will Atossa Therapeutics Inc. stock split in the near futureDynamic investment growth - jammulinksnews.com

12:27 PM
pulisher
Jul 24, 2025

Is Atossa Therapeutics Inc. a good long term investmentJaw-dropping returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

How Atossa Therapeutics Inc. stock reacts to Fed policy changesStrongest growth potential - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Atossa Therapeutics Inc. stockHigh-return market picks - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Atossa Therapeutics Inc. stock priceExceptional profit potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Atossa Therapeutics Inc. Stock Analysis and ForecastSuperior returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Atossa Therapeutics Inc. stock attracts strong analyst attentionHigh Potential Safe Trades - Newser

Jul 22, 2025
pulisher
Jul 18, 2025

Should I buy Atossa Therapeutics Inc. stock before earningsHigh Win Rate Stock Ideas - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

How Atossa Therapeutics Inc. stock performs during market volatilityDaily Gain Forecast - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Atossa Therapeutics Inc. stock price move sharplyTrade With Low Risk Exposure - Newser

Jul 15, 2025
pulisher
Jul 07, 2025

Ascendiant Lifts Atossa Therapeutics, Inc. (ATOS) Target Citing Strong Liquidity - MSN

Jul 07, 2025
pulisher
Jun 26, 2025

15 Best Growth Stocks to Invest in for the Next 5 Years - Insider Monkey

Jun 26, 2025
pulisher
Jun 15, 2025

Millennium Management LLC Purchases Shares of 29,149 Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World

Jun 15, 2025
pulisher
Jun 09, 2025

Atossa Therapeutics, Inc. (NASDAQ:ATOS) Shares Purchased by Two Sigma Advisers LP - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Ascendiant Capital Markets Issues Positive Forecast for Atossa Therapeutics (NASDAQ:ATOS) Stock Price - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Craig Hallum Upgrades Atossa Therapeutics (NASDAQ:ATOS) to “Strong-Buy” - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Atossa Therapeutics (ATOS): Ascendiant Capital Raises Price Targ - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Ascendiant Capital raises Atossa Genetics stock price target to $7.50 By Investing.com - Investing.com India

Jun 06, 2025
pulisher
Jun 06, 2025

Ascendiant Capital raises Atossa Genetics stock price target to $7.50 - Investing.com

Jun 06, 2025
pulisher
Jun 06, 2025

Craig-Hallum Initiates Coverage of Atossa Therapeutics (BMV:ATOS) with Buy Recommendation - Nasdaq

Jun 06, 2025
pulisher
Jun 05, 2025

Craig-Hallum Initiates Coverage of Atossa Therapeutics (ATOS) with Buy Recommendation - Nasdaq

Jun 05, 2025
pulisher
Jun 05, 2025

This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Jun 05, 2025
pulisher
Jun 05, 2025

Craig-Hallum Initiates Coverage on Atossa Therapeutics (ATOS) with Buy Rating | ATOS Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Atossa Therapeutics at Jefferies Conference: Strategic Moves in Breast Cancer - Investing.com Canada

Jun 05, 2025

Atossa Therapeutics Inc Azioni (ATOS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):